Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet. The Company’s integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.

Company Growth (employees)
Blacksburg, US
Size (employees)
832 (est)+30%
Intrexon was founded in 1998 and is headquartered in Blacksburg, US

Key People at Intrexon

Randal J. Kirk

Randal J. Kirk

CEO and Chairman
Eli Groban

Eli Groban

Gregory Frost

Gregory Frost

Senior Vice President, Health Sector
Robert F. Walsh, III

Robert F. Walsh, III

Senior Vice President, Energy Sector
Thomas D. Reed

Thomas D. Reed

Founder & Chief Science Officer, Board of Directors
Samuel Broder

Samuel Broder

Chairman, Health Sector

Intrexon Office Locations

Intrexon has office in Blacksburg
Blacksburg, US

Intrexon Metrics

Intrexon Summary

Market capitalization

$2.4 b

Closing share price

Intrexon's current market capitalization is $2.4 b.

Intrexon Financials

Intrexon's revenue is $23.8 m in FY, 2013 which is a 67% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$23.8 m$71.9 m$173.6 m$190.9 m

Revenue growth, %


Gross profit

$63.7 m$150.4 m

Operating expense total

$81.8 m$141.9 m$320.5 m


($57.4 m)($64.7 m)($137.9 m)

Net Income

($40.9 m)($85.6 m)($88 m)($190.3 m)

Operating cash flow

$39.1 m($22 m)$108.3 m

Intrexon Market Value History

Intrexon Online Presence

Intrexon Company Life

You may also be interested in